{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T04:17:00Z","timestamp":1790223420155,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","jdsjournal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Dermatological Science"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.jdermsci.2016.05.004","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T10:43:09Z","timestamp":1465641789000},"page":"182-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":52,"title":["Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma"],"prefix":"10.1016","volume":"83","author":[{"given":"Sadanori","family":"Furudate","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6809-5833","authenticated-orcid":false,"given":"Taku","family":"Fujimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Kakizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takanori","family":"Hidaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Asano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Setsuya","family":"Aiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jdermsci.2016.05.004_bib0005","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/1346-8138.12305","article-title":"Immunological milieu in mycosis fungoides and S\u00e9zary syndrome","volume":"41","author":"Miyagaki","year":"2014","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0010","doi-asserted-by":"crossref","first-page":"3768","DOI":"10.1182\/blood-2004-09-3502","article-title":"WHO-EORTC classification for cutaneous lymphomas","volume":"105","author":"Willemze","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0015","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1038\/jid.2011.470","article-title":"Low herpesvirus entry mediator (HVEM) expression on dermal fibroblasts contributes to a Th2-dominant microenvironment in advanced cutaneous T-cell lymphoma","volume":"132","author":"Miyagaki","year":"2012","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0020","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/exd.12873","article-title":"The possible interaction between periostin expressed by cancer stroma and tumor-associated macrophages in developing mycosis fungoides","volume":"25","author":"Furudate","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0025","doi-asserted-by":"crossref","first-page":"19446","DOI":"10.1073\/pnas.0706832104","article-title":"CD4+CD25+Foxp3+ regulatory T cells induce alternative activation of human monocytes\/macrophages","volume":"104","author":"Tiemessen","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0030","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1038\/jid.2015.199","article-title":"The possible interaction between receptor activator of nuclear factor kappa-B ligand (RANKL) expressed by extramammary Paget cells and its ligand on dermal macrophages","volume":"135","author":"Kambayashi","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0035","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1007\/s10787-013-0177-5","article-title":"The multiple faces of CCL13 in immunity and inflammation","volume":"21","author":"Mendez-Enriquez","year":"2013","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0040","doi-asserted-by":"crossref","first-page":"2820","DOI":"10.1158\/1078-0432.CCR-14-3322","article-title":"The use of transcriptional profiling to improve personalized diagnosis and management of Cutaneous T-Cell Lymphoma (CTCL)","volume":"21","author":"Litvinov","year":"2015","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0045","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1038\/jid.2014.206","article-title":"Depletion of M2-like tumor-associated macrophages delays cutaneous T-cell lymphoma development in vivo","volume":"134","author":"Wu","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0050","doi-asserted-by":"crossref","first-page":"e1047584","DOI":"10.1080\/2162402X.2015.1047584","article-title":"Immunomodulatory effect of peritumoral administration of interferon-beta on melanoma through tumor-associated macrophages","author":"Kakizaki","year":"2015","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0055","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1038\/jid.2015.209","article-title":"Receptor activator of nuclear factor kappa-B ligand (RANKL) promotes the production of CCL17 from RANK+ M2 macrophages","volume":"135","author":"Fujimura","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0060","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1159\/000365946","article-title":"Comparison of CD163+ CD206+ M2 macrophages in the lesional skin of bullous pemphigoid and pemphigus vulgaris: the possible pathogenesis of bullous pemphigoid","volume":"229","author":"Furudate","year":"2014","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0065","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1016\/j.ajpath.2011.05.040","article-title":"Up-regulation of the chemokine CCL18 by macrophages is a potential immunomodulatory pathway in cutaneous T-cell lymphoma","volume":"179","author":"G\u00fcnther","year":"2011","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0070","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1038\/jid.2013.488","article-title":"The role of IL-32 in cutaneous T-cell lymphoma","volume":"134","author":"Suga","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0075","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1182\/blood-2005-04-1492","article-title":"Skin homing of S\u00e9zary cells involves SDF-1-CXCR4 signaling and down-regulation of CD26\/dipeptidylpeptidase IV","volume":"107","author":"Narducci","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0080","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/cncr.10706","article-title":"Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma","volume":"95","author":"Sileni","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0085","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1080\/10428190410001693560","article-title":"Cutaneous T-Cell lymphoma: a paradigm for biological treatment","volume":"45","author":"Pichardo","year":"2004","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0090","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/1346-8138.12341","article-title":"Phase II study of i.v. interferon-gamma in Japanese patients with mycosis fungoides","volume":"41","author":"Sugaya","year":"2014","journal-title":"J. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0095","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.immuni.2010.05.007","article-title":"Alternative activation of macrophages: mechanism and functions","volume":"32","author":"Gordon","year":"2010","journal-title":"Immunity"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0100","doi-asserted-by":"crossref","first-page":"7303","DOI":"10.4049\/jimmunol.177.10.7303","article-title":"Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression","volume":"177","author":"Martinez","year":"2006","journal-title":"J. Immunol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0105","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1001\/archderm.138.8.1054","article-title":"Treatment of cutaneous T cell lymphoma with combined immunomodulatory therapy","volume":"138","author":"Suchin","year":"2002","journal-title":"Arch. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0110","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1002\/cncr.10706","article-title":"Phase II trial of interferon-alpha-2a plus psolaren with ultraviolet light A in patients with cutaneous T-cell lymphoma","volume":"95","author":"Sileni","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000077303","article-title":"CCR4 Expression by atypical T cells in systemic pilotropic lymphoma: its behavior under treatment with interferon gamma, topical PUVA and systemic retinoid","volume":"208","author":"Fujimura","year":"2004","journal-title":"Dermatology"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0120","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1179\/1607845415Y.0000000002","article-title":"Interferon and low doses of methotrexate versus interferon and retinoids in the treatment of refractory\/relapsed cutaneous T-cell lymphoma","volume":"20","author":"Aviles","year":"2015","journal-title":"Hematology"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0125","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1468-3083.2011.04011.x","article-title":"Comparison of pegylated interferon \u03b1-2b plus psoralen PUVA versus standard interferon \u03b1-2a plus PUVA in patients with cutaneous T-cell lymphoma","volume":"26","author":"H\u00fcsken","year":"2012","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0130","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1182\/blood-2014-07-588236","article-title":"Lack of durable disease control with chemotherapy for mycosis fungoides and S\u00e9zary syndrome: a comparative study of systemic therapy","volume":"125","author":"Hughes","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0135","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1182\/blood-2009-11-251926","article-title":"Sezary syndrome and mycosis fungoides arise from distinct T-cell subsets: a biologic rationale for their distinct clinical behaviors","volume":"116","author":"Campbell","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0140","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1182\/blood-2014-09-600924","article-title":"Phase 1\/2 study of mogamulizumab, a defucosylated anti-CCR4 antibody, in previously treated patients with cutaneous T-cell lymphoma","volume":"125","author":"Duvic","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0145","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/jid.2009.45","article-title":"Cutaneous T-cell lymphoma: roles for chemokines and chemokine receptors","volume":"129","author":"Wu","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0150","doi-asserted-by":"crossref","first-page":"e60","DOI":"10.1111\/j.1468-3083.2012.04495.x","article-title":"Increased CCL18 expression in patients with cutaneous T-cell lymphoma: association with disease severity and prognosis","volume":"27","author":"Miyagaki","year":"2013","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0155","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature15520","article-title":"Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy","volume":"527","author":"Peng","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0160","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/j.vaccine.2013.07.066","article-title":"Enhancement of antigen-specific CD8T cell responses by co-delivery of Fc-fused CXCL11","volume":"32","author":"Namkoong","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0165","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/exd.12894","article-title":"Mac attack: macrophages as key drivers of cutaneous T-cell lymphoma pathogenesis","volume":"25","author":"Assaf","year":"2016","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.jdermsci.2016.05.004_bib0170","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/nrg3185","article-title":"Insights into the regulation of protein abundance from proteomic and transcriptomic analyses","volume":"13","author":"Vogel","year":"2012","journal-title":"Nat. Rev. Genet."},{"issue":"Pt. B","key":"10.1016\/j.jdermsci.2016.05.004_bib0175","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.addr.2015.11.009","article-title":"Tumor-associated macrophages: potential therapeutic targets for anti-cancer therapy","volume":"99","author":"Komohara","year":"2016","journal-title":"Adv. Drug Deliv. Rev."}],"container-title":["Journal of Dermatological Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116300743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923181116300743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T12:41:59Z","timestamp":1568032919000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923181116300743"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0923181116300743"],"URL":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.05.004","relation":{},"ISSN":["0923-1811"],"issn-type":[{"value":"0923-1811","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tumor-associated M2 macrophages in mycosis fungoides acquire immunomodulatory function by interferon alpha and interferon gamma","name":"articletitle","label":"Article Title"},{"value":"Journal of Dermatological Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jdermsci.2016.05.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Japanese Society for Investigative Dermatology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}